Generic Name and Formulations:
Ethacrynic acid 25mg; scored tabs.
Valeant Pharmaceuticals, Inc
Indications for EDECRIN:
Treatment of edema when greater diuretic potential is required.
Initially 50–100mg daily; adjust in 25–50mg increments. Usual maintenance: 50–200mg daily or intermittently.
See Contraindications. Initially 25mg; adjust gradually in 25mg increments (see literature).
Anuria. Infants. If severe, watery diarrhea occurs, discontinue use and do not restart.
Renal impairment. Hepatic cirrhosis. Monitor weight, renal function, electrolytes, CO2, BUN. Potassium supplementation may be needed. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Digitalis, lithium toxicity. May alter excretion of lithium. Potentiates warfarin. Antagonized by NSAIDs. Orthostatic hypotension with antihypertensives. Ototoxicity with aminoglycosides, other ototoxic agents. May alter glucose tolerance tests.
GI upset, anorexia, malaise, abdominal pain, dysphagia, ototoxicity, vertigo, headache, rash, electrolyte imbalance, hyperuricemia, gout, hyperglycemia; rare: agranulocytosis, severe neutropenia, thrombocytopenia.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D